No impact of COVID-19 at delivery on maternal mortality or infant adverse birth outcomes in Botswana during the Omicron era
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0310980 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jaspreet Banga und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America. Hauptthemen laut MEDLINE: COVID-19, Pregnancy Complications, Infectious, Maternal Mortality, SARS-CoV-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NICHD NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
SARS-CoV-2 infection during pregnancy was associated with maternal mortality and adverse birth outcomes in the pre-Omicron era, including a stillbirth rate of 5.6% in Botswana. We re-evaluated these outcomes in the Tsepamo Study during the Omicron era. We assessed maternal mortality and adverse birth outcomes for all singleton pregnancies from mid-November 2021 (the start of the Omicron era) to mid-August 2022 at nine Tsepamo sites, among individuals with documented SARS-CoV-2 screening PCR or antigen tests and known HIV status. Of 9,705 women routinely screened for SARS-CoV-2 infection at delivery (64% of deliveries at these sites), 373 (3.8%) tested positive. Women with HIV were as likely to test positive for SARS-CoV-2 (77/1833, 4.2%) as women without HIV (293/6981, 4.2%) (p = 1.0). There were 5 recorded maternal deaths (0.03%), one occurring in a woman with a positive SARS-CoV-2 test result. In contrast, maternal mortality was 3.7% and 0.1% in those with and without SARS-CoV-2, respectively, during the pre-Omicron era. In the Omicron era, there were no differences among infants exposed or unexposed to SARS-CoV-2 in overall adverse birth outcomes (28.1% vs 29.6%; aRR 1.0, 95%CI 0.8–1.1), severe adverse birth outcomes (11.9 vs 10.6%; aRR 1.1, 95%CI 0.8–1.5), preterm delivery (15.1% vs 14.9%; aRR 1.0, 95%CI 0.8–1.3), or stillbirth (1.9% vs 2.3%; aRR 0.8, 95%CI 0.4–1.7). Adverse outcomes among those exposed to both HIV and SARS-CoV-2 were similar to those exposed to HIV alone (31.2% vs. 33.1%; aRR 0.9, 95%CI 0.6–1.3; p = 0.5). Maternal mortality was far lower in Botswana during the Omicron era than in the pre-Omicron era, and adverse birth outcomes were no longer significantly impacted by exposure to SARS-CoV-2 either overall or with HIV co-exposure. Increased population immunity to SARS-CoV-2, less stress on the hospital systems in the Omicron era, and possible differences in viral pathogenicity may combine to explain these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
- Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
- Botswana Harvard Health Partnership, Gaborone, Botswana.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
- Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
- Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
ORCID-Profile: Jaspreet Banga, Sikhulile Moyo
Förderung
- NIAID NIH HHS
- NICHD NIH HHS
- NCI NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Banga, J., Jackson-Gibson, M., Diseko, M., Caniglia, E. C., Mayondi, G., Mabuta, J., Luckett, R., Moyo, S., Smith-Lawrence, P., Mosepele, M., Lockman, S., Makhema, J., Zash, R., & Shapiro, R. (2024). No impact of COVID-19 at delivery on maternal mortality or infant adverse birth outcomes in Botswana during the Omicron era. PLOS ONE. https://doi.org/10.1371/journal.pone.0310980
Vancouver
Banga J, Jackson-Gibson M, Diseko M, Caniglia EC, Mayondi G, Mabuta J, et al. No impact of COVID-19 at delivery on maternal mortality or infant adverse birth outcomes in Botswana during the Omicron era. PLOS ONE. 2024. doi:10.1371/journal.pone.0310980
BibTeX
@article{Banga2024,
author = {Banga, Jaspreet and Jackson-Gibson, Maya and Diseko, Modiegi and Caniglia, Ellen C and Mayondi, Gloria and Mabuta, Judith and Luckett, Rebecca and Moyo, Sikhulile and Smith-Lawrence, Pamela and Mosepele, Mosepele and Lockman, Shahin and Makhema, Joseph and Zash, Rebecca and Shapiro, Roger},
title = {No impact of COVID-19 at delivery on maternal mortality or infant adverse birth outcomes in Botswana during the Omicron era},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0310980}
}
EUVIMED